The term 'pyrexia' is often used synonymously with fever in the UK. Fever should be distinguished from hyperthermia, which is an unregulated rise in body temperature due to a failure of temperature homeostasis. 2 Over 100 years ago Wunderlich recorded multiple temperature measurements on around 25,000 people. He defined normal body temperature as 37°C and suggested that the upper limit of the normal range should be regarded as 38°C. 3 This has formed the basis for subsequent definitions of fever. Petersdorf and Beeson provided the classic definition of 'fever of unknown origin' (FUO) as a prolonged febrile illness of at least three weeks' duration, with repeated temperature measurements of 38.3°C or higher, that defies diagnosis after one week of hospital inpatient evaluation. 4 This has subsequently been modified to remove the requirement that investigations are performed in the inpatient setting because most patients can be evaluated as outpatients.
Fever of unknown origin
One problem with the definition of FUO is that it does not specify which investigations should have been performed prior to stating that a patient fulfils the definition. This is probably responsible for many of the reported differences in the frequency of FUO attributed to infection, neoplasm, collagen vascular disease and miscellaneous causes. Arnow and Flaherty have suggested a minimum set of investigations to be performed prior to so defining a patient (Table 1) . 5 Adoption of these criteria is recommended to attempt to establish greater comparability between future publications on FUO.
It has been suggested that FUO can be subclassified into four different types:
Only the definition of classic FUO specifies that the patient must have had fevers for at least three weeks. 6 This may potentially cause confusion; it is probably preferable to restrict the term FUO to those cases where FUO has been present for at least three weeks and to exclude HIV and immune deficiency. Unfortunately, many clinicians use the term loosely to include any fever for which a cause has not been found. This should be strongly discouraged because the most likely causes of short-term fevers which have not been thoroughly There is substantial variation between the different series. In particular, collagen vascular diseases were less frequent causes of FUO in earlier case series than presently. In resource poor countries FUO is more frequently due to infections than in established market economies. 6 This may partly represent differences in the geographic and temporal distribution of diseases, but is also explained by the thoroughness of the investigations performed prior to classifying a patient as having FUO and the diagnostic tests subsequently available to investigate it. For example, the availability of highly sensitive blood culture techniques and high quality echocardiography means that bacterial endocarditis is now a less common cause of FUO because the condition can be diagnosed relatively easily and is therefore unlikely to meet the FUO criteria.

Infectious diseases
Causes of fever of unknown origin
Children and young adults
The relative likelihood of FUO being due to specific causes is related to the age of the patient. In children, infections are the most common cause. Jacobs and Schutze found that 64 of 164 children with FUO had infections including Epstein-Barr virus infection, osteomyelitis, bartonellosis and urinary tract infections. 8 Many children with FUO recover without a diagnosis ever being established. A cause is not found in over 40% of children under 18 years with FUO compared with less than 5% for adults over 65 years. 9 However, joint disease in children with FUO suggests a serious underlying disorder such as connective tissue disease (CTD), endocarditis or leukaemia. 10 Still's disease, an important cause of FUO in children, can also affect young adults and is a condition often neglected during the search for a cause. Malignancy is a relatively uncommon cause in children 8 and young adults, 11 but lymphoma is a potential diagnosis which is important to exclude because delay in diagnosis may adversely affect prognosis.
The elderly
Haematologic malignancies and solid tumours are more common causes of FUO in elderly patients than in younger adults. 11, 12 Infections and CTDs are also frequent causes in the elderly. Temporal arteritis and polymyalgia rheumatica are particularly common in this age group. Symptoms of temporal arteritis may be CME non-specific, such as lethargy and general malaise, which may result in diagnostic delay and risk of blindness from retinal artery occlusion.
Approach to diagnosis
The investigations to be performed prior to defining a patient as having FUO are listed in Table 1 . There are many potential causes of FUO so it is not possible to list a standard battery of tests which should be performed to investigate every case. It is preferable to tailor the investigations according to clues which may have been suggested by the history and repeated physical examinations. Table 3 lists clues to the cause of an FUO suggested by information identified from the history. 13 Repeated, careful and targeted physical examination may reveal physical signs missed on previous examinations. It is worth documenting a careful examination of the sinuses for tenderness, the oropharynx, fundi, skin and nails, thyroid gland, lymph nodes, external genitalia and rectum. All too frequently these are omitted from the physical examination or performed in a cursory way and important signs omitted. This can result in diagnostic delay and wasted resources performing unnecessary tests. Table 4 indicates clues to the cause of an FUO which may be elicited by physical examination (this list is not exhaustive).
Treatment
Disease-modifying treatment
In considering treatment of FUO, the concern is essentially with symptomatic treatment because, by definition, the underlying disease is unknown. Specific disease-modifying treatment can usually be commenced only once the diagnosis has been established. The exception is when empirical drug therapy is used to CME Infectious diseases Medication attempt to confirm or refute a suspected diagnosis. Giving empirical antibiotic therapy for a patient with an FUO is usually not appropriate. If the fever responds without a specific diagnosis being established, there is a risk that an important condition such as endocarditis may be missed. This may result in a potentially adverse outcome in that the endocarditis is suppressed but not cured and the patient subsequently relapses.
Empirical therapy with antituberculosis drugs can be used as a therapeutic trial if extrapulmonary tuberculosis (TB) appears likely, but there is little potential for obtaining a positive mycobacterial culture. However, if rifampicin is included among the empirical anti-TB drugs it must be remembered that this antibiotic could suppress fever in many other conditions including brucellosis and osteomyelitis. Therefore, many clinicians omit rifampicin from therapeutic trials of anti-TB drugs.
Symptomatic treatment
There are two important issues to take into account when considering symptomatic treatment:
1 Will the symptomatic treatment mask the clinical signs and thus hinder diagnosis?
2 Could the symptomatic treatment affect the prognosis of any of the potential differential diagnoses?
Antipyretic agents. Antipyretic drugs are frequently overprescribed in patients with fevers, particularly among inpatients with recent onset of fever. The masking of temperature by paracetamol and non-steroidal drugs can lead to the erroneous conclusion that a patient is recovering. Therefore, fever in hospitalised patients should usually be treated only if it poses a threat to the patient or is causing substantial discomfort. Treatment of fever is less likely to obscure the diagnosis in patients with an established FUO than in hospital inpatients with recent symptoms. This is both because the established fever is unlikely to subside completely and because the longer duration of symptoms means that apparent short-term resolution of fever should be interpreted with caution. Historically, the pattern of fever has been said to correlate with specific conditions, but this is rarely diagnostically useful in the individual patient (except perhaps in malaria). Antipyretic drugs are unlikely to affect the prognosis of conditions causing FUO, so it is not unreasonable to give them to patients with FUO if they are suffering discomfort, particularly if they are being investigated as outpatients.
Steroids. If corticosteroids are used as a therapeutic trial, they may mask symptoms (eg rashes and fever). If the patient has an underlying haematological malignancy, steroids may potentially adversely affect future treatment response. Thus, if a therapeutic trial of steroids is being considered for a suspected CTD such as temporal arteritis or polymyalgia rheumatica, the clinician needs to be certain that the patient does not have an occult lymphoma or other malignancy.
Summary
There are many potential causes of FUO. Most cases are due to unusual presentations of common diseases rather than rare or exotic diseases. The key to establishing the diagnosis is a careful history and careful repeated examinations followed by targeted investigations.
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